Navigation Links
Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results
Date:4/23/2008

SAN DIEGO, April 23 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report first quarter 2008 financial results on Wednesday, April 30, 2008, after the U.S. financial markets close.

Anadys will hold a conference call and webcast to discuss its first quarter 2008 financial results and highlights and to provide an update on its development programs on Wednesday, April 30, 2008 at 5:00 p.m. Eastern Daylight Time. A live webcast of the call will be available online at http://www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 65984063. The webcast and telephone replay will be available through May 14, 2008.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. The Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5b polymerase for the treatment of chronic hepatitis C, and ANA773, an oral TLR7 agonist prodrug for cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines in the areas of hepatitis C and oncology. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be mater
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...hed the Sixth Milestone in its Ofatumumab ...N, Denmark, October 10 /- G...d the sixth milestone for,ofatumumab (HuMax-CD20(R...SmithKline (GSK). A milestone payment of approxima...) was triggered by the first patient,receiving tre...
(Date:10/10/2008)...Oct. 10 /Xinhua-- Beike,Biotechnology...bal leader in,stem cell research and treatment thr...as signed eight separate mutual cooperation agreem...anding stem cell research organizations.,As part o...em Cell Expert,Advisory Committee" and a separate ...
(Date:10/10/2008)...RNewswire/ -- Twenty of Britain,s most,innovative ...bit their,ideas at the fifth annual SETsquared Par...eld at One Great George Street, London, from 8am o...m of technology innovators,in electronics, informa...Six companies will give 10-minute presentations to...
(Date:10/10/2008)...Newswire/ -- Takeda Pharmaceutical Company,Limited...earch and,Development Center, Inc., a wholly owned...ation that the U.S. Food and Drug Administration (...e alogliptin New Drug Application,(NDA) by the Pre...r 27,2008., "In our most recent discussion with ...
Breaking Biology Technology:Genmab Reaches Milestone in Ofatumumab Collaboration 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2
...er company looks to reclaim lost ground , ,CHIPPE... be operating out of offices on Lowater Road here ...hip to new and wonderful heights. , ,With its next... the company with the name in supercomputing is lo...orate eye that, just a few years ago, had nearly b...
...anced Research Projects Agency (DARPA), has awarde...Development under the DARPA Super High Efficienc...that could increase the funding to a total award o... in 1998, last week received a $4.6 million contra...inging their total dollars in new contracts and gr...
...the 1990s, it used to be that every company needed...foosball money could buy to launch their business....pany than to be one so you could attract great emp...ecame very profitable for companies like Herman Mi...nt companies. , ,Obviously, this has changed. Com...
...ays companies do business. , ,MADISON, WI- From o...World Wide Web and all it offers can equip busines...tomer satisfaction and, as a result, profits. It h... where companies use Internet-enabled technologies... deliver value to customers in entirely new ways. ...
Other Biology Technology:Cray Rides Again 2Cray Rides Again 3Alfalight Gets $3.8M From DARPA - Funding has increased to $8.5 Million 2The Top 10 Musts That Should Be in Your Business Survival Kit 2The Top 10 Musts That Should Be in Your Business Survival Kit 3Institute Helps Industries Enhance Business Strategies 2Institute Helps Industries Enhance Business Strategies 3Institute Helps Industries Enhance Business Strategies 4
(Date:10/10/2008)... previously unknown relationship between stem cell...ria a cell,s energy makers. Stem cells with more a... differentiate and are more likely to form tumors....could lead to methods of enriching the best stem c... provide some insights into the role of stem cells...
(Date:10/10/2008)...MADISON Governor Jim Doyle today announced a hist... institutions to advance personalized health care ...diseases. The Wisconsin Genomics Initiative is a c...Clinic, Medical College of Wisconsin (MCW), Univer...alth (UWSMPH) and UW-Milwaukee (UWM). , Wisconsi...
(Date:10/10/2008)...the 1950s, Austrian and Swiss scientists conducted...taking photographs of the glaciers, mountains and ...ist Fritz Mller spent eight months in the region a...raphing the Himalayan glaciers. , Now, fifty yea... these scientists are of immense value in trying t...
(Date:10/10/2008)...e in German . , DNA, the molecule that acts a...of life, is highly resistant against alteration by...m for its photostability presents some puzzling pr...e four chemical bases that make up the DNA molecul...n showing that DNA strands differ in their light s...
Breaking Biology News(10 mins):Governor Doyle announces historic genomic research collaboration 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3Can genetic information be controlled by light? 2Marital Stress Linked to Heart Disease 4431 1Marital Stress Linked to Heart Disease 4431 2Marital Stress Linked to Heart Disease 4431 3Los Angeles Red Cross Aids Thousands of Wildfire Evacuees 4427 1Los Angeles Red Cross Aids Thousands of Wildfire Evacuees 4427 2Fires Put Pregnant Women Infants at Risk 4423 1Fires Put Pregnant Women Infants at Risk 4423 2Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 1Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 2Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 3
...key role in mediating the outcome of competition b...ease-bearing conquistadors in the New World--or, o...bacteria to spread their viruses to competing bact...o different general ways in which bacteria compete...trategy seems to be particularly effective under d...
...sionals and the general public alike have been acu...ult from a flu pandemic. Although many people migh...is the infamous 1918-1920 pandemic--and the possib...he most trepidation. , Strangely, researchers s...this particular strain of the flu virus in that pa...
...m global warming? Perhaps, but the tradeoffs invol...ear waste generated each year and a greatly increa...sion of nuclear material into terrorists, hands. ...dney Ewing, who has analyzed just how much nuclear...reduce greenhouse gas emissions worldwide, and the...
...rategy for infecting cornea cells that may also ex...o a study by researchers at the University of Illi...appears in the Sept. 25 issue of the Journal of Ce...- HSV-1, the strain that causes cold sores on the ... cornea, the clear, domed surface that forms the e...
Other Biology News:Different strategies underlie the ecology of microbial invasions 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3Plutonium or greenhouse gases? Weighing the energy options 2Study shows how herpes infects cornea, evades immune cells 2
Hybridization Buffer 3.6 ml
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215
Glutathione Agarose Beads 10 ml
Biology Products: